| MSDS | : | MVI-12 VIAL 1 & VIAL 2 UNIT VIAL | | CAS | : | 57-55-6
9005-65-6
9005-66-7
128-37-0
25013-16-5
77-92-9
68-04-2
1310-73-2
50-81-7
79-81-2
50-14-6
67-03-8
83-88-5
58-56-0
98-92-0
81-13-0
7695-91-2
58-85-5
59-30-3
68-19-9 | | NAME | : | 1,2-propanediol (propylene glycol)
polysorbate 80 usp, polyoxyethylenesorbitol oleate, tween
polysorbate 40, polyoxyethylene 20 sorbital monopalmitate
2,6-di-tert-butyl-p-cresol, butylate hydroxy toluene, bht,
butylhydroxyanisol (animal carcinogen by iarc - group 2b,
citric acid
sodium citrate, trisodium salt, citric acid
sodium hydroxide, caustic soda, lye
gentisic acid ethanolamide
l-ascorbic acid, ascorbic acid
retinol palmitate
ergocaliciferol
thiamine hydrochloride
riboflavin (5-phosphate sodium)
pyridoxine hydrochloride
niacinamide
dexpanthenol
tocopheryl acetate *95-1*
biotin
folic acid
cyanocobalamin
|
| |
|
|
===================== Product Identification =====================
MSDS NAME:MVI-12 VIAL 1 & VIAL 2 UNIT VIAL
NIIN:01-105-0048
MSDS Number: BWXSV
=== Responsible Party ===
Company:ASTRA PHARMACEUTICAL PRODUCTS INC
Address:50 OTIS ST
City:WESTBOROUGH
State:MA
ZIP:01581-3323
Country:US
Info Phone Num:508-366-1100/800-225-6333
Emergency Phone Num:800-225-6333/508-366-1100
CAGE:04473
=== Contractor Identification ===
Company:ASTRA PHARMACEUTICAL PRODUCTS INC
Address:50 OTIS ST
Box:City:WESTBOROUGH
State:MA
ZIP:01581-3323
Country:US
Phone:508-366-1100/800-225-6333
CAGE:04473
============= Composition/Information on Ingredients =============
Name:1,2-PROPANEDIOL (PROPYLENE GLYCOL)
CAS:57-55-6
RTECS #:TY2000000
Fraction by Wt: 30%
Name:POLYSORBATE 80 USP, POLYOXYETHYLENESORBITOL OLEATE, TWEEN
80
CAS:9005-65-6
RTECS #:WG2932500
Fraction by Wt: 0.8-1.6%
Name:POLYSORBATE 40, POLYOXYETHYLENE 20 SORBITAL MONOPALMITATE
CAS:9005-66-7
RTECS #:WG2933000
Fraction by Wt: <0.1%
Name:2,6-DI-TERT-BUTYL-P-CRESOL, BUTYLATE HYDROXY TOLUENE, BHT,
ANTIOXIDANT (IARC GROUP 3) *95-1*
CAS:128-37-0
RTECS #:GO7875000
Fraction by Wt: <0.1%
ACGIH TLV:10 MG/CUM
Name:BUTYLHYDROXYANISOL (ANIMAL CARCINOGEN BY IARC - GROUP 2B,
SUSPECTED CARCINOGEN BY NTP) *95-1*
CAS:25013-16-5
RTECS #:SL1945000
Fraction by Wt: <0.1%
Name:CITRIC ACID
CAS:77-92-9
RTECS #:GE7350000
Fraction by Wt: <1%
Name:SODIUM CITRATE, TRISODIUM SALT, CITRIC ACID
CAS:68-04-2
RTECS #:GE8300000
Fraction by Wt: <1%
Name:SODIUM HYDROXIDE, CAUSTIC SODA, LYE
CAS:1310-73-2
RTECS #:WB4900000
Other REC Limits:2MG/M3 CEILING NIOSH
OSHA PEL:2 MG/CUM
ACGIH TLV:2 MG/CUM CEILING
EPA Rpt Qty:1000 LBS
DOT Rpt Qty:1000 LBS
Name:GENTISIC ACID ETHANOLAMIDE
Fraction by Wt: 1-2%
Name:L-ASCORBIC ACID, ASCORBIC ACID
CAS:50-81-7
RTECS #:CI7650000
Fraction by Wt: 1-2%
Name:RETINOL PALMITATE
CAS:79-81-2
RTECS #:VH6860000
Fraction by Wt: <0.1%
Name:ERGOCALICIFEROL
CAS:50-14-6
RTECS #:KE1050000
Fraction by Wt: <0.1%
Name:THIAMINE HYDROCHLORIDE
CAS:67-03-8
RTECS #:XI7350000
Fraction by Wt: <0.1%
Name:RIBOFLAVIN (5-PHOSPHATE SODIUM)
CAS:83-88-5
RTECS #:VJ1400000
Fraction by Wt: <0.1%
Name:PYRIDOXINE HYDROCHLORIDE
CAS:58-56-0
RTECS #:UV1350000
Fraction by Wt: <0.1%
Name:NIACINAMIDE
CAS:98-92-0
RTECS #:QS3675000
Fraction by Wt: 0.4-0.8%
Name:DEXPANTHENOL
CAS:81-13-0
RTECS #:ES4316000
Fraction by Wt: .15-0.3%
Name:TOCOPHERYL ACETATE *95-1*
CAS:7695-91-2
RTECS #:GA8747000
Fraction by Wt: 0.1-0.2%
Name:BIOTIN
CAS:58-85-5
RTECS #:XJ9088200
Fraction by Wt: <0.1%
Name:FOLIC ACID
CAS:59-30-3
RTECS #:LP5425000
Fraction by Wt: <0.1%
Name:CYANOCOBALAMIN
CAS:68-19-9
RTECS #:GG3750000
Fraction by Wt: <0.1%
===================== Hazards Identification =====================
Routes of Entry: Inhalation:NO Skin:YES Ingestion:YES
Reports of Carcinogenicity:NTP:YES IARC:YES OSHA:NO
Health Hazards Acute and Chronic:EYES/SKIN: IRRITATION. MAY CAUSE
ALLERGIC REACTION IN SENSITIVE INDIVIDUALS. LARGE INGESTION OF
VITAMIN A & D MAY RESULT IN TOXICITY. POTENTIAL REPRODUCTIVE TOXIN.
Explanation of Carcinogenicity:SEE INGREDIENTS.
Effects of Overexposure:ITCHING, REDNESS, FATIGUE, LETHARGY, DIARRHEA,
VOMITING, NAUSEA, SEVERE HEADACHE, STUPOR, SEIZURES, SWEATING,
RAPID RESPIRATION & HEART RATE
Medical Cond Aggravated by Exposure:REPRODUCTIVE ABNORMALITIES DURING
PREGNANCY.
======================= First Aid Measures =======================
First Aid:SKIN/EYES: FLUSH THOROUGHLY W/CLEAR WATER FOR 15 MINS. OBTAIN
MEDICAL ATTENTION IN ALL CASES.
===================== Fire Fighting Measures =====================
Extinguishing Media:WATER, DRY CHEMICAL, CO2/FOAM AS APPROPRIATE FOR
ADJACENT MATERIALS.
Fire Fighting Procedures:WEAR SCBA & PROTECTIVE CLOTHING.
Unusual Fire/Explosion Hazard:TOXIC FUMES CAN BE EMITTED IN A FIRE.
================== Accidental Release Measures ==================
Spill Release Procedures:ABSORB W/INERT MATERIALS.
====================== Handling and Storage ======================
Handling and Storage Precautions:AVOID EXPOSURE TO LIGHT. KEEP SEALED
UNTIL USED. STORE AT 36-46F.
Other Precautions:AVOID INGESTION. MINIMIZE SKIN & EYE CONTACT.
============= Exposure Controls/Personal Protection =============
Respiratory Protection:NONE NECESSARY.
Ventilation:LOCAL EXHAUST
Protective Gloves:GENERAL PURPOSE DISPOSABLE/REUSABLE
Eye Protection:EYE GLASSES/SAFETY GLASSES
Other Protective Equipment:NONE NECESSARY
Supplemental Safety and Health
================== Physical/Chemical Properties ==================
Boiling Pt:B.P. Text:194-212F
Melt/Freeze Pt:M.P/F.P Text:<32F
Vapor Pres:17.9
Vapor Density:<1
Spec Gravity: 1
Solubility in Water:COMPLETE
Appearance and Odor:PALE YELLOW LIQUID
================= Stability and Reactivity Data =================
Stability Indicator/Materials to Avoid:YES
NONE
Stability Condition to Avoid:LIGHT
Hazardous Decomposition Products:TOXIC FUMES WHEN HEATED TO
DECOMPOSITION.
==================== Disposal Considerations ====================
Waste Disposal Methods:DISPOSE BY INCINERATION IAW/LOCAL, STATE &
FEDERAL REGULATIONS.
Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
*** END OF RECORD *** |
|
|